Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

Presentation TCT 2022

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Presenter: ShaoLiang Chen

September 18, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Opinion Off Script

To Save a Dying Mother

Kathryn J. Lindley, MD

June 28, 2022

News Features

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

Todd Neale

June 24, 2022

News Daily News

Cardio-Obstetrics Merits Better Training, Wider Uptake: Survey

Caitlin E. Cox

April 26, 2022

News Daily News

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Michael O'Riordan

April 25, 2022

News Conference News ACC 2022

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

Michael O'Riordan

April 02, 2022

News Conference News ACC 2022

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

Todd Neale

April 02, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

Advertisement

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

New Faces, New Formats, New Tech: What to Expect From TCT 2022

What’s Going to Be Hot at ESC 2022?

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

To Save a Dying Mother

As US Abortion Protections Are Lost, Cardiologists Brace for Impact

Cardio-Obstetrics Merits Better Training, Wider Uptake: Survey

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

More Evidence Links Breast Arterial Calcification and CVD Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content